The biggest proposed IPO in biotech history just got even bigger.
Cambridge-based Moderna Therapeutics disclosed Wednesday that it's hoping to raise up to $600 million in an initial public offering, an increase from the $500 million maximum it proposed earlier this month. Either sum would shatter the previous record for a life sciences IPO, both in biotech-rich Massachusetts and nationwide.